Abstract Library

#2732 Prostate Metastasis of Medullary Thyroid Carcinoma in a Young Patient with MEN2B Syndrome

Introduction: Multiple Endocrine Neoplasia 2B is associated with particularly early onset medullary thyroid carcinoma (MTC). Metastatic MTC is the leading cause of early death in MEN2B. The usual sites of metastasis are neck, mediastinum, lung, liver, bone and brain.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Noble J

Authors: Noble J, Forde H, Crowley R,

Keywords: Neuroendocrine, MEN2B, Medullary Thyroid Cancer, Prostate Metastasis, Calcitonin, Multiple Endocrine Neoplasia,

#2201 Early Prognostic Factors in Medullary Thyroid Carcinoma

Introduction: Medullary thyroid carcinoma (MTC) prognosis has been related with several variables, being calcitonin doubling time one of the most important prognostic factor. However, it is not evaluable in the early postoperative period.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Muñoz de Nova J, Di Martino M, Marín Campos C, Lahera Vargas M, Mora Guzmán I,

Keywords: medullary thyroid carcinoma, thyroid surgery, prognosis,

#2029 Prognostic Factors of Pulmonary Carcinoid Tumors

Introduction: Pulmonary carcinoids (PC) are rare malignant neoplasms that account for approximately 1% of all lung cancers. PCs are classified by histological criteria as either typical (TC) or atypical (AC). Histological subtype is the most studied prognostic factor.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Vesterinen T

Authors: Vesterinen T, Mononen S, Salmenkivi K, Mustonen H, Ilonen I,

Keywords: pulmonary carcinoids, prognosis,

#2014 Imaging of Advanced Medullary Thyroid Carcinoma with the CCK-2 Receptor Agonist 177Lu-PP-F11N – Preliminary Proof of the Principle within the “Lumed” Study

Introduction: Despite the introduction of new molecular targeted therapies, there is still an unmet need for an effective systemic therapy for advanced medullary thyroid carcinoma (MTC). Targeting the cholecystokinine-2 (CCK-2) receptor with radiolabeled gastrin analogues is a potential approach for radionuclide therapy of MTC.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Rottenburger C, Nicolas G, McDougall L, Kaul F, Christ E,

Keywords: Medullary thyroid carcinoma, cholecystokinine-2 receptor, radionuclide therapy, theranostics,

#2009 Retrospective Epidemiologic Study of Medullary Cancer of Thyroid Gland in Hospital – Based Registry in Moscow Cancer Centre

Introduction: Medullary cancer of thyroid gland comes from calcitonin secreting C-cells.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Komarova L, Tabolinovskya T, Pirogova N, Machaladze Z,

Keywords: registry, NETs,